COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,388 Articles (22,816 medRxiv, 8,572 bioRxiv)

Most recent first Previous |  Page 2063: Articles 20621-20630  | Next

A precise measure of the impact of the first wave of Covid-19 on life expectancy. Regional differentials in Switzerland
Wanner, P.
10.1101/2020.11.19.20234716 — Posted: 2020-11-19
Knowledge and perceptions on COVID-19 among Senior High School students in Ghana: a cross-sectional study
Lettor, I. B. k., Apanga, P. A., Kumbeni, M. T., Akunvane, R., Akparibo, R.
10.1101/2020.11.18.20234088 — Posted: 2020-11-19
Early chains of transmission of COVID-19 in France
Paireau, J., Mailles, A., Eisenhauer, C., de Laval, F., Delon, F., Bosetti, P., Salje, H., Ponties, V., Cauchemez, S.
10.1101/2020.11.17.20232264 — Posted: 2020-11-19 Discussion: Offsite
Forecasting the spread of COVID19 in Hungary
Khanday, O. M., Dadvandipour, S., Lone, M. A.
10.1101/2020.11.19.20234815 — Posted: 2020-11-19
Assessment of COVID-19 vaccine acceptance among healthcare workers in Los Angeles
Gadoth, A., Halbrook, M., Martin-Blais, R., Gray, A. N., Tobin, N. H., Ferbas, K. G., Aldrovandi, G. M., Rimoin, A. W.
10.1101/2020.11.18.20234468 — Posted: 2020-11-19
Social patterning and stability of COVID-19 vaccination acceptance in Scotland: Will those most at risk accept a vaccine?
Williams, L., Flowers, P., McLeod, J., Young, D., Rollins, L., CATALYST project team
10.1101/2020.11.19.20234682 — Posted: 2020-11-19
Antibodies to SARS-CoV-2 are associated with protection against reinfection
Lumley, S. F., O'Donnell, D., Stoesser, N. E., Matthews, P. C., Howarth, A., Hatch, S. B., Marsden, B. D., Cox, S., James, T., Warren, F., Peck, L. J., Ritter, T. G., de Toledo, Z., Warren, L., Axten, D., Cornall, R. J., Jones, E. Y., Stuart, D. I., Screaton, G., Ebner, D., Hoosdally, S., Chand, M., Oxford University Hospitals Staff Testing Group, , Crook, D. W., O'Donnell, A.-M., Conlon, C. P., Pouwels, K. B., Walker, A. S., Peto, T. E., Hopkins, S., Walker, T. M., Jeffery, K., Eyre, D. W.
10.1101/2020.11.18.20234369 — Posted: 2020-11-19 Discussion: Onsite
Natural deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape
McCarthy, K. R., Rennick, L. J., Nambulli, S., Robinson-McCarthy, L. R., Bain, W. G., Haidar, G., Duprex, W. P.
10.1101/2020.11.19.389916 — Posted: 2020-11-19 Discussion: Onsite | Offsite
SARS-CoV-2 infection suppresses ACE2 function and antiviral immune response in the upper respiratory tract of infected patients
Gutierrez-Chamorro, L., Riveira-Munoz, E., Barrios, C., Palau, V., Massanella, M., Garcia-Vidal, E., Badia, R., Pedreno, S., Senserrich, J., Rodriguez, E., Clotet, B., Cabrera, C., Mitja, O., Crespo, M., Pascual, J., Riera, M., Ballana, E.
10.1101/2020.11.18.388850 — Posted: 2020-11-19
Improved production of SARS-CoV-2 spike receptor-binding domain (RBD) for serology assays
Mehalko, J., Drew, M., Snead, K., Denson, J.-P., Wall, V., Taylor, T., Sadtler, K., Messing, S., Gillette, W., Esposito, D.
10.1101/2020.11.18.388868 — Posted: 2020-11-18

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).